Ticker
INMCompany Name
INMED PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 11.08M | 6.02 | $ 1.84M |
3/31/2025 | $ 4.68M | 2.54 | $ 1.84M |
12/31/2024 | $ 3.42M | 1.91 | $ 1.79M |
9/30/2024 | $ 5.58M | 3.89 | $ 1.44M |
6/30/2024 | $ 6.57M | 3.33 | $ 1.97M |
3/31/2024 | $ 7.6M | 4.97 | $ 1.53M |
12/31/2023 | $ 9.53M | 5.67 | $ 1.68M |
9/30/2023 | $ 6.74M | 5.03 | $ 1.34M |
6/30/2023 | $ 8.91M | 4.45 | $ 2M |
3/31/2023 | $ 9.6M | 4.23 | $ 2.27M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for INMED PHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 4.5M ] / LiabilitesC [ $ 1.87M ]
(=) Cash Ratio [ 2.4 ]
Minimum
Mar 31, 2022
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |